Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H14O4S |
| Molecular Weight | 266.313 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC2=C(C=C(S2)C(O)=O)C=C1OCC
InChI
InChIKey=PDUXMHXBBXXJFQ-UHFFFAOYSA-N
InChI=1S/C13H14O4S/c1-3-16-9-5-8-6-12(13(14)15)18-11(8)7-10(9)17-4-2/h5-7H,3-4H2,1-2H3,(H,14,15)
| Molecular Formula | C13H14O4S |
| Molecular Weight | 266.313 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tibenelast is an orally active phosphodiesterase inhibitor that was undergoing phase II clinical trials in the USA as a bronchodilator. In preclinical studies Tibenelast is moderately active against the lung and stomach enzyme while being a very weak inhibitor of the heart enzyme and it does not inhibit enzymes involved in arachidonic acid metabolism. Tibenelast shows potent anti-anaphylactic activity in guinea pigs without cardiovascular effects at the bronchodilatory doses.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:40 GMT 2025
by
admin
on
Mon Mar 31 18:24:40 GMT 2025
|
| Record UNII |
H051V8LJ93
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10243289
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111055
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
H051V8LJ93
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
6159
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
C72863
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
100000082164
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
SUB11019MIG
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
97852-72-7
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
108930
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY | |||
|
59913
Created by
admin on Mon Mar 31 18:24:40 GMT 2025 , Edited by admin on Mon Mar 31 18:24:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |